Home' Australian Pharmacist : Australian Pharmacist February 2012 Contents Australian Pharmacist February 2012 I © Pharmaceutical Society of Australia Ltd.
of each of their patients. Regard for
pharmacists as health professionals and
respect for their medicines knowledge
is not routinely acknowledged by
health practitioners and they are
not automatically included in multi-
However, pharmacists do have an
important contribution to make in
providing pro-active, multi-disciplinary
team care, especially for older patients
with multiple chronic conditions.
A patient-centred model of care
has already been developed for the
pharmacy profession and pharmacy
organisations to draw upon to
inform their practice. It is timely for
pharmacists to fulfil their potential,
meet their patient responsibilities and
routinely interact with other health
practitioners to provide professional
medicines knowledge and become
integral members of health care teams.
Australian Government health reforms
aim to co-locate health practitioners
and support multidisciplinary team
approaches and the time is ideal for all
involved in the pharmacy profession,
including educational institutions,
to move forward in this area.
Education for pharmacists and
Counter Connection – A monthly
distance education module for
Facts Behind the Fact Cards – Monthly
detailed clinical and practice education
for pharmacists. CPD points are available.
Self Care Your professional edge
Health information for your customers
Fact Cards – Fact Cards provide
independent, concise and factual
information for the pharmacy team
Health campaigns – Comprehensive
health promotion pharmacy
packages designed to educate and
raise public awareness.
Promotion tools for your pharmacy
John Bell’s Health Column – Self Care
Adviser, John Bell, writes an informative
weekly column that can be personalised
to member pharmacies and used in
local media such as newspapers and
Pharmacy’s leading health information and education program Join now at www.psa.org.au/selfcare or call 1300 369 772
1. Can you please talk about how you
currently approach the management
of patients with multiple chronic
conditions – what happens now?
2. If you have experienced any
structural issues that affect the
way you practice, and barriers
to providing patient-centred care,
can you talk about some of these?
3. If you have talked about a lack
of time as a barrier to providing
patient-centred care, are there
any other structural barriers to
providing more holistic care or to
being more pro-active in monitoring
4. What are your experiences of
communicating with patients?
5. Do you routinely discuss with
patients their medicines, the risks
and benefits associated with their
medicines, positives and negatives?
6. If yes, what are some of the issues
7. How well is this matched with what
you think should happen in practice?
8. Can you talk about your experiences
of communication between
health practitioners in relation
to older people with multiple
9. What are the issues that affect
communication between health
10.Can you talk about some of the
social and non-medical issues that
affect your patient’s health?
1. Caughey GE, et al. Prevalence of comorbidity of chronic
diseases in Australia. BioMed Central Public Health,
2. Australian Government, Department of Health and Ageing,
Building a 21st Century Primary Health Care System.
Australia’s First National Primary Health Care Strategy.
ISBN: 978-1 -74241-224-5 Publication number: 6594.
Commonwealth of Australia: Canberra, 2010.
3. Commonwealth of Australia, A National Health and
Hospitals Network for Australia’s Future: Delivering better
health and better hospitals. 2010 [cited 17/11/11], At:
4. Australian Commission on Safety and Quality in Health
Care. Patient-Centred Care: Improving Quality and
Safety by Focusing Care on Patients and Consumers
— Discussion Paper. 2010 [cited 17/11/11]; At: www.
5. Rigby D. Pharmacists’ Culture - the Ultimate Barrier?
Pharmacist, 2011;30 - Oct #10.
6. Cipolle R, Strand L, Morley P. Pharmaceutical care practice.
1998: McGraw-Hill, New York.
7. Hepler CD, Strand LM. Opportunities and responsibilities in
pharmaceutical care. American Journal of Hospital Pharmacy,
8. Australian Department of Health and Ageing (2010) Fifth
Community Pharmacy Agreement Fact Sheet. 2010 [cited
17/11/11], At: www.health.gov.au/internet/main/publishing.
9. Emblem G, Miller E. Home medicines review: The how and
why for GPs. Aust Fam Phys, 2004;33(1):49–51.
10. Patton MQ. Qualitative Evaluation and Research Methods
(2nd Ed). 1990, Newbury Park, California, United States of
11. Cheek J, Onslow M, Cream A. Beyond the divide: Comparing
and contrasting aspects of qualitative and quantitative
research approaches. Advances in Speech Language
Pathology, 2004;6(3):147–52 .
12. Australian Government Department of Health and Ageing
(2011) Medicare Item 723. 2010 [cited 17/11/11], At: www.
13. Dey R, de Vries MJW, Bosnic-Anticevich S. Collaboration in
chronic care: unpacking the relationship of pharmacists and
general medical practitioners in primary care. International
Journal of Pharmacy Practice, 2010;19:21-30 .
14. McLean W, Gillis J, Waller R. The BC Community Pharmacy
Asthma Study: A study of clinical, economic and holistic
outcomes influenced by asthma care protocol provided by
specially trained community pharmacists in British Columbia.
Canadian Respiratory Journal, 2003;10:195–202.
15. Saini B, Krass I, Armour C. Development, implementation and
evaluation of a community pharmacy-based asthma care
model. Annals of Pharmacotherapy, 2004;38:1954–60 .
16. Mangiapane S, et al. Community pharmacy-based
pharmaceutical care for asthma patients. Annals of
Pharmacotherapy, 2005;39:1817–22 .
17. Emmerton L, Shaw J, Kheir N. Asthma management
by New Zealand pharmacists: a pharmaceutical care
demonstration project. Journal of Clinical Pharmacy
Appendix A – Discussion topics – Health practitioners
Links Archive Australian Pharmacist March 2012 Australian Pharmacist January 2012 Navigation Previous Page Next Page